Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J L Godden
Lonafarnib Reduces the Resistance of Primitive Quiescent CML Cells to Imatinib Mesylate in Vitro
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo
Acta Pharmacologica Sinica
Medicine
Pharmacology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition
International Journal of Molecular Medicine
Medicine
Genetics
CML: Langzeitresultate Zum Imatinib-Stopp
Im Focus Onkologie
MATE1 Regulates Cellular Uptake and Sensitivity to Imatinib in CML Patients
Blood Cancer Journal
Oncology
Hematology
Imatinib Mesylate Causes Growth Plate Closure in Vivo
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
A Novel BCR-Abl Splice Isoform Is Associated With the L248V Mutation in CML Patients With Acquired Resistance to Imatinib
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
